FDA has issued a box warning of the risk of thyroid cancers and are contraindicated liraglutide, exenatide (once weekly), and semaglutide (both oral and injectable) in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia types 2 A or 2B [135, 136]
Being prepared sets you up for success no matter which treatment you choose
In her personal experience, Dr
In: Methods in Enzymology, Packer, L
Reducing sodium intake is particularly important, as excess sodium can contribute to high blood pressure
Nausea, vomiting, and diarrhea are most likely to feel when starting this medication